According to Hanyu Pharmaceutical, on the afternoon of December 31, 2024, four members of the Huawei Technology Co., Ltd. delegation included Li Songmeng, general manager of the Shenzhen Government-Enterprise Pan-Enterprise Systems Department; Dong Wei, head of the Shenzhen Government and Enterprise Intelligent Manufacturing Development Department; Wang Xiang, director of Shenzhen Cloud Native Biomedical Solutions; and Dai Yunlong, representative of the Shenzhen government and enterprise biomedical industry, visited Hanyu Pharmaceutical for exchanges and cooperation. While visiting Hanyu Pharmaceutical's product showroom and R&D center, the Huawei delegation learned more about Hanyu Pharmaceutical's strategic vision, development history, product pipeline, and R&D technology. In the discussion that followed, the two sides thoroughly discussed the application of the HUAWEI Cloud Pangu Pharmaceutical Molecular Model in the fields of drug design and development, peptide platform construction, and digital transformation to enable enterprise efficiency improvement, as well as the application prospects of artificial intelligence in the global pharmaceutical industry.

Zhitongcaijing · 01/01 06:49
According to Hanyu Pharmaceutical, on the afternoon of December 31, 2024, four members of the Huawei Technology Co., Ltd. delegation included Li Songmeng, general manager of the Shenzhen Government-Enterprise Pan-Enterprise Systems Department; Dong Wei, head of the Shenzhen Government and Enterprise Intelligent Manufacturing Development Department; Wang Xiang, director of Shenzhen Cloud Native Biomedical Solutions; and Dai Yunlong, representative of the Shenzhen government and enterprise biomedical industry, visited Hanyu Pharmaceutical for exchanges and cooperation. While visiting Hanyu Pharmaceutical's product showroom and R&D center, the Huawei delegation learned more about Hanyu Pharmaceutical's strategic vision, development history, product pipeline, and R&D technology. In the discussion that followed, the two sides thoroughly discussed the application of the HUAWEI Cloud Pangu Pharmaceutical Molecular Model in the fields of drug design and development, peptide platform construction, and digital transformation to enable enterprise efficiency improvement, as well as the application prospects of artificial intelligence in the global pharmaceutical industry.